1,900 Shares in Innospec Inc. (NASDAQ:IOSP) Purchased by Point72 Asset Management L.P.

Point72 Asset Management L.P. purchased a new stake in shares of Innospec Inc. (NASDAQ:IOSP) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,900 shares of the specialty chemicals company’s stock, valued at approximately $215,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. CWM LLC boosted its holdings in shares of Innospec by 239.6% in the 2nd quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock worth $78,000 after acquiring an additional 448 shares in the last quarter. SG Americas Securities LLC boosted its stake in Innospec by 660.1% in the second quarter. SG Americas Securities LLC now owns 9,767 shares of the specialty chemicals company’s stock worth $1,207,000 after purchasing an additional 8,482 shares in the last quarter. Assenagon Asset Management S.A. grew its holdings in shares of Innospec by 98.4% during the second quarter. Assenagon Asset Management S.A. now owns 120,082 shares of the specialty chemicals company’s stock worth $14,841,000 after purchasing an additional 59,554 shares during the last quarter. Leeward Investments LLC MA increased its stake in shares of Innospec by 5.6% in the second quarter. Leeward Investments LLC MA now owns 70,254 shares of the specialty chemicals company’s stock valued at $8,683,000 after buying an additional 3,706 shares in the last quarter. Finally, ZWJ Investment Counsel Inc. lifted its position in Innospec by 2.7% during the 2nd quarter. ZWJ Investment Counsel Inc. now owns 41,643 shares of the specialty chemicals company’s stock worth $5,147,000 after buying an additional 1,112 shares in the last quarter. 96.64% of the stock is currently owned by institutional investors and hedge funds.

Innospec Price Performance

IOSP stock opened at $115.74 on Friday. The company has a 50 day moving average price of $115.45 and a 200 day moving average price of $117.62. Innospec Inc. has a fifty-two week low of $103.97 and a fifty-two week high of $133.71. The stock has a market capitalization of $2.89 billion, a PE ratio of 20.20 and a beta of 1.09.

Innospec (NASDAQ:IOSP) last released its earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.35. The company had revenue of $443.40 million during the quarter, compared to the consensus estimate of $442.13 million. Innospec had a return on equity of 13.33% and a net margin of 7.68%. The firm’s quarterly revenue was down 4.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.59 earnings per share. As a group, equities analysts expect that Innospec Inc. will post 5.88 earnings per share for the current fiscal year.

Innospec Increases Dividend

The firm also recently announced a Semi-Annual dividend, which was paid on Tuesday, November 26th. Stockholders of record on Monday, November 18th were paid a $0.79 dividend. This represents a dividend yield of 1.3%. The ex-dividend date of this dividend was Monday, November 18th. This is a positive change from Innospec’s previous Semi-Annual dividend of $0.72. Innospec’s dividend payout ratio (DPR) is 27.57%.

Insider Transactions at Innospec

In related news, Director Milton C. Blackmore sold 1,035 shares of the company’s stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $122.92, for a total value of $127,222.20. Following the completion of the sale, the director now owns 9,028 shares in the company, valued at approximately $1,109,721.76. This represents a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 1.52% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Innospec from a “buy” rating to a “strong-buy” rating in a research note on Tuesday.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.